Quantcast

Latest Gastroenterology Stories

2014-10-24 08:26:10

BOSTON, Oct. 24, 2014 /PRNewswire/ -- Rhythm announced today the presentation of results from a Phase 2a clinical trial assessing the safety and efficacy of relamorelin (RM-131) in 48 patients with chronic constipation. Analysis of the data indicates that relamorelin administered once daily for two weeks in patients with chronic constipation significantly improves constipation symptoms, along with accelerating colonic transit. The study results were presented in a late-breaker session at the...

2014-10-22 12:30:14

Presentations examine certain demographic and clinical disease characteristics that may be indicative of Cimzia® treatment response and remission for moderate to severe Crohn's disease ATLANTA, Oct. 22, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on CNS and immunology treatment and research, is sponsoring several data presentations on Cimzia(®) (certolizumab pegol) at the American College of Gastroenterology's (ACG) 2014 Annual Scientific Meeting in Philadelphia,...

2014-10-22 08:32:25

-- Relamorelin is a Novel Peptide Ghrelin Agonist for Diabetic Gastroparesis -- DUBLIN and BOSTON, Oct. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced that Actavis has been granted an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Health, Inc., which is developing relamorelin (RM-131), a peptide ghrelin agonist, for the treatment of diabetic...

2014-10-22 08:31:07

NORWALK, Conn., Oct. 22, 2014 /PRNewswire/ -- Recently published clinical studies of Stretta for gastroesophageal reflux disease (GERD) have bolstered the already substantial database of evidence. This data has led to significantly expanded insurance coverage and adoption of Stretta therapy for sufferers of refractory GERD. The substantial body of clinical evidence supporting Stretta therapy as a safe and effective GERD treatment has driven new coverage policies that make Stretta...

2014-10-22 04:22:24

Immune Pharmaceuticals Recently Initiated Phase II Clinical Trial in Ulcerative Colitis CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Oct. 22, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces that Dr. Tomer Adar, a gastro-enterologist at the Institute for Digestive Diseases at Shaare Zedek Medical Center, Israel, is presenting today at the United European Gastro-Enterology week in Vienna, Austria an abstract entitled "The...

2014-10-20 08:32:07

LONDON, October 20, 2014 /PRNewswire/ -- Norgine B.V. today announced that the Phase II study of its novel, low volume bowel preparation, NER1006, presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology (ACG), Philadelphia, PA, has met its primary efficacy end point of stool weight and co-primary endpoint of cleansing success. The study demonstrated high quality bowel cleansing efficacy with NER1006 vs. MOVIPREP(R) in screening colonoscopy...

2014-10-20 08:31:51

BRIDGEWATER, N.J., Oct. 20, 2014 /PRNewswire/ -- Valeritas, Inc., a leader in simple, disposable basal-bolus insulin delivery technology designed for patients with Type 2 diabetes, announced today that it has received a 2014 Cardinal Health Supply Chain Excellence Award. The award was presented October 16(th) at Cardinal's annual Business Partners Conference in Columbus, Ohio. The Cardinal Health Supply Chain Excellence Award recipients are judged across a variety of metrics...

2014-10-20 08:30:48

VIENNA, October 20, 2014 /PRNewswire/ -- A major pan-European survey into the burden of gastrointestinal (GI) disorders and the delivery of care has revealed changing trends in many important GI and liver diseases and worrying inequalities in the provision of healthcare services across the continent. The results of the survey, which was commissioned by United European Gastroenterology (UEG), have been announced today and led to calls for greater political and public awareness...

2014-10-15 08:29:01

-- Mark Pimentel, M.D., FRCP(C), of Cedars-Sinai Medical Center Serves as Chairman -- ROCKVILLE, Md., Oct. 15, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologics and drugs targeting specific pathogens that cause serious infections and diseases, announced today the expansion of its Clinical Advisory Board (CAB) created to support development of SYN-010, the Company's statin-class candidate intended to...

2014-10-14 23:04:38

A chronic and often progressive ailment affecting 1 out of 5 people Walnut Creek, CA (PRWEB) October 14, 2014 Dr. Wilson Tsai, in partnership with Bay Area Surgical Specialists (BASS) announces the establishment of the Heartburn Center of California to combat Gastroesophageal Reflux Disease (GERD), a chronic and often progressive disease affecting 64 million Americans. The visionary and holistic approach of diagnosing and treating the disease at the Heartburn Center of California goes...


Latest Gastroenterology Reference Libraries

Duodenal Atresia
2013-07-19 15:38:56

Duodenal atresia is a congenital closure of the lumen of the duodenum, which is the first portion of the small intestine and is separated from the stomach by the pyloric sphincter. During fetal development, the duodenum develops from the posterior portion of the foregut and the anterior portion of the midgut. The liver and pancreas originate from the diverticulum arising from the ventral part of the duodenum, and the bile duct runs along the ventral free side of the duodenum. Rotation and...

Small Intestine
2013-03-04 15:13:09

The small intestine is the part of the digestive tract that follows the stomach and is followed by the large intestine. Formation and Orientation The small intestine is on average between 22 feet 6 inches and 24 feet 4 inches. It is composed of three distinct structural parts; the duodenum, the jejunum, and the ileum. The duodenum is the part of the intestine where most chemical breakdown happens; it is also the shortest part of the intestine. It starts at the duodenal bulb and stops...

Stomach
2013-03-04 14:34:35

The stomach is the hollow organ that helps along digestion after mastication (chewing). It is the next step after the esophagus and before the small intestines. Formation and Orientation The stomach is composed of four parts. The cardia is the first part of the stomach in the digestive tract. It is the part of the stomach that allows the food to empty from the esophagus. The most northern part of the stomach is the Fundus. This section is the part that creates the curved part of the...

Gastroscopy
2013-03-04 10:13:56

The esophagogastroduodenoscopy is a medical diagnostic procedure used in internal medicine to view the upper part of the gastrointestinal tract. This non-invasive procedure is used for many complaints and requires little to no time for recovery from the procedure. Reasons for the Procedure Patients present to their physician with physical complaints. For example, a patient may come into the office and say they have been feeling tired and forgetful. Through many tests and evaluations,...

Esophagus
2012-07-01 19:23:24

The Esophagus is an organ which consists of a muscular tube through which food passes from the pharynx to the stomach. During swallowing, food passes from the mouth through the pharynx into the esophagus and travels to the stomach via peristalsis -- a radially symmetrical contraction and relaxation of muscles that propagate in a wave downward. The word esophagus is derived from the Greek word oisophagos, meaning “entrance for eating.” In humans the esophagus is continuous with the...

More Articles (11 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin